Catalyst Wire Dossier Catalyst Wire Dossier

NGX-4010

capsaicin patch 8% · NeurogesX
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for NGX-4010, covering 2008-01-11 to 2011-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy [Phase 3]

See pricing